100 Misguided Lawmakers Could Undermine American Universities


By Brian O'Shaughnessy

American universities have long attracted the best and brightest from around the world. They come for the sophisticated research opportunities that prevail in academic labs -- funded, in part, by American taxpayer dollars.

But with taxpayer dollars comes political scrutiny. One-hundred members of Congress proposed a reinterpretation of the law that fuels this world-class R&D engine. And their short-term political ploy, if adopted, would undermine U.S. leadership in higher education.

Back in the 1970s, leaders in Congress realized that America's research apparatus was not achieving all that it could. While federal funds supported groundbreaking research in academic labs across the nation, those funds came with strings attached. Namely, the government retained title to patents if they arose from research funded in any part by taxpayer dollars.

And the government did a poor job of finding companies willing to invest in turning that patented basic research into actual, useful products. The feds licensed fewer than 5% of those patents to the private sector.

University and small business leaders proposed a solution to this waste: decentralization. Rather than Washington bureaucrats licensing federally funded inventions, universities and small companies themselves could license patents they developed with government support.

Formalized in a bipartisan 1980 law colloquially known as the Bayh-Dole Act, this arrangement unleashed a frenzy of university research and successful commercialization.

Thanks to the current congressional proposal, however, Bayh-Dole and sponsored research at America's universities could soon be eviscerated.

Hoping to find a silver bullet to cut drug prices, lawmakers zeroed in on an obscure provision of the Bayh-Dole Act. It allows the government to "march in" and relicense patents derived from federally funded research in a few rare circumstances.

These lawmakers, however, want to twist the original intent of this provision in hopes of marching in on innovative products that, thanks to Bayh-Dole, are already on the market. Essentially, they're proposing to use march-in rights as de facto price controls.

The authors of the 1980 law definitively stated that Congress never intended to grant such authority to the federal government.

And for good reason. If the private sector believed that the government could rip up carefully negotiated license agreements on a whim, firms would not license university research, nor would they pour hundreds of millions, or even billions, of dollars into sponsoring academic research and then developing that research into useful commercial products.

We've already run this experiment. In 1989, the federal government began inserting a "reasonable pricing clause" into patent licenses and cooperative research and development agreements (CRADAs) between federally funded academic institutions and the private sector.

Instead of lowering drug prices, however, this policy repelled private industry from collaborating with academia.

Resurrecting these failed policies would once again deal a blow to America's research universities. The opportunity to perform research, and collaborate with industry, attracts thousands of bright foreign students to the United States every year. By and large, these students stay in the country and help America maintain a net positive trade imbalance in "intellectual capital."

Gutting American academic research means that more of those students will take their talent and their tuition dollars to competing markets. That'd be a tragic outcome.

Destroying Bayh-Dole's virtuous research and development cycle could upend American higher education. That's an unfathomably high price to pay. Let's not do it.

Brian O'Shaughnessy is chair of the IP Transactions and Licensing Group of Dinsmore & Shohl, LLP, and a past president of the Licensing Executives Society (USA & Canada), Inc. He also serves as chair of the Bayh-Dole Coalition Board of Directors. This piece originally appeared in RealClearEducation.



More Resources


05/02/2024
Biden's Electoral College Challenge
President Joe Biden won a decisive Electoral College victory in 2020 by restoring old Democratic advantages in the Rust Belt while establishing new beachheads in the Sun Belt.

more info


05/02/2024
Unredactions Reveal White House Role in Trump Documents Case
Top Biden administration officials worked with the National Archives to develop Special Counsel Jack Smith's case against Donald Trump involving the former president's alleged mishandling of classified material, according to recently unsealed court documents in the case pending in southern Florida.

more info


05/02/2024
Student Unrest Ratchets Up an Already Tense Election Year
Dramatic campus protests are injecting an inflammatory new element into an election year that is already threatening to stretch national unity to a breaking point.

more info


05/02/2024
Campus Protests an Extension of BLM Riots 4 Yrs Ago
The Federalist's Mollie Hemingway on Wednesday's 'Special Report' addressed how the Biden White House is handling the Israel-Palestine conflict and anti-Israel protests across the nation.

more info


05/02/2024
Why Campus Chaos Should Give Democrats PTSD
New York City police, dressed in riot gear, descending on Columbia University, breaking up protests and arresting college students. It's hard not to have flashbacks to 1968.

more info


05/02/2024
GOP Right Flank Challenges Speaker Johnson (and Trump)
House Speaker Mike Johnson has a revolt on his right flank, and by extension, so does Donald Trump. The former president has certainly tightened his grasp on the Republican Party as he seeks to return to the White House. All the same, his authority is not complete.

more info


05/02/2024
Google Manipulation Threatens Another Election
In less than six months, Americans will head to the polls.

more info


05/02/2024
Want To Know How To Reduce Gun Crime? Look at Detroit
Last year, Detroit saw its fewest homicides since 1966. Here's how it did it - and how other cities can do the same.

more info


05/02/2024
Sham Science
The dean of the Case Western Reserve Medical School recently urged the medical profession to embrace "inclusive scholarship." Dean Stan Gerson's arguments for doing so epitomize the falsehoods that govern academic life today.

more info


05/02/2024
No, the 'Extreme Left' Hasn't Killed Comedy
The comedian's claim that wokeness is the reason why comedy is no longer as funny is lazy - and inaccurate

more info


05/02/2024
Swing-State Voters Reject Biden's Appliance Restrictions
Two-thirds of registered voters in swing states rejected President Joe Biden's climate policy restrictions on appliances, according to a new survey.

more info


05/02/2024
How Colleges Are Responding to Protests
Wednesday on the RealClearPolitics radio show, Andrew Walworth, Tom Bevan, and Carl Cannon discuss how college administrations are responding to pro-Palestinian protests on campus and a new trend of allowing non-citizens to vote in U.S. elections.

more info


05/02/2024
Universities Aren't Our Best and Brightest Anymore
Joe Rogan and Tulsi Gabbard speak about the situation on college campuses:

more info


05/02/2024
Want To Get Into Harvard? Show Off Your Trauma
In this clip, Tyler Austin Harper and guest host John McWhorter discuss university admissions policies that incentivize students to engage in performances of their identity. In the ever-tightening race for admission into elite schools, Tyler and John agree, applicants who can fulfill universities' desire for a "diverse" student body stand a better chance. With explicit racial identification outlawed by last year's Students for Fair Admissions Supreme Court decision, essays that play up students' identity-based struggles have become one of the only ways for applicants to signal their "diverse"...

more info


05/02/2024
Milgram in the Modern Day: Psychology of Antisemitism
Mere days after Columbia's president testified the university was doing "everything it can" against antisemitism, extremist protestors took over the campus, threatening and attacking Jewish students, encouraging others to become "martyrs" like the Hamas terrorists who committed the Oct. 7 massacre, and calling for Oct. 7 to become "every day" for Jews worldwide. After Jewish community leaders called for Jewish students to leave Columbia, President Shafik moved all classes online.

more info



Custom Search

More Politics Articles:

Related Articles

Americans Can't Afford Insurance — and Obamacare is to Blame


The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

ICER Discriminates Against People with Rare Diseases


FDA officials approved a record number of rare disease treatments last year. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

Minor Legislation with Massive Implications


U.S. Senator Ron Johnson (R-WI) is promoting the "Prevent Government Shutdown Act of 2019." The goal of the act is to prevent disruptive government shutdowns.

When Humans Don't Procreate


The "hook" of the story intrigued me: "This hasn't happened in all of modern history..." An email from "The Crux" last month blared, "Global population growth to virtually stop by 2100."

Beware of Bills in Sheep's Clothing


There is a bipartisan tradition of naming bills such that no reasonable person would oppose them. For instance, changes to our tax system came with the passage of the Tax Cuts and Jobs Act. Who's against jobs? And how could anyone have voted against the Patient Protection and Affordable Care Act (i.e., "Obamacare")?

Offshore Bans Hurt Working Class Americans


Congressional Democrats just betrayed America's working class.

If You Like Your Health Plan, You Can't Keep It Under a Public Option


Nearly two in three Americans support the creation of a government-sponsored health plan to compete against plans offered by private insurers, according to the most recent survey data from the Kaiser Family Foundation.

Don't Legalize Discrimination Against People With Disabilities


Imagine if the federal government treated disabled Americans as second-class citizens. It's an appalling thought. But it could happen soon -- if some special interest groups get their way.

It's Time to Turn the Prescription Drug Debate on its Head


Politicians typically blame drug companies for soaring pharmacy prices. But insurers, pharmacies, and other middlemen are the real driving force behind rising drug spending.

U.S. Carbon Emissions Are Actually Dropping


Increased natural gas consumption helped bring down U.S. greenhouse gas emissions in 2019, according to a recent report from the U.S. Energy Information Administration.

"Buy American" Executive Order Could Slow Delivery of a Coronavirus Cure


President Trump is considering a "Buy American" executive order requiring government agencies to purchase medicines and medical supplies domestically.

Don't Disrupt the Supply Chain in the Midst of a Pandemic


The Trump administration fears America has lost its ability to mass-produce the medicines and medical supplies needed to fight the coronavirus and other, future pandemics. So it's considering an executive order to bring drug and medical-supply manufacturing back to the United States.

Intellectual Property Makes Sure Drug Makers Deliver


House Democrats Peter DeFazio, Rosa DeLauro, Lloyd Doggett, and Jan Schakowsky want to nullify intellectual property rights on any experimental treatments for COVID-19. They believe their proposals will prevent "price gouging and profiteering" without harming innovation.

Move These Projects Forward and Get America Back to Work


With more than 40 million Americans out of a job due to the coronavirus pandemic, states are scrambling to help the unemployed and laying plans to reopen the economy.

COVID-19 Cost-Effectiveness Research Deepens Racial Disparities


A newly released study by the Institute for Clinical and Economic Review (ICER), a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the coronavirus?